Skip to content

TREK™ 1012279-12Recalls & reported problems

Abbott Vascular Inc. · TREK™ Coronary Dilatation Catheter 4.50 mm x 12 mm / Rapid-Exchange · Class 2

All models of TREK (50)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08717648138751), received between Nov 16, 2017 and Aug 14, 2025 — classified as 2 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Material Rupture” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Rupture3
  • Material Separation2
  • Material Split, Cut or Torn1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • No Consequences Or Impact To Patient2
  • Device Embedded In Tissue or Plaque1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 14, 2025Material Rupture; Material Separation; Material Rupture; Material Separation

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN OSTIAL RIGHT CORONARY ARTERY (RCA) WITH HEAVY CALCIFICATION AND MILD TORTUOSITY. THE 4.5X12MM TREK BALLOON DILATATION CATHETER (BDC) WAS ADVANCED TO THE TARGET LESION AND THE BALLOON WAS INFLATED TO NOMINAL PRESSURE; HOWEVER, THE BALLOON RUPTURED DURING THE FIRST INFLATION AND PIECE OF THE BALLOON SEPARATED. A STENT WAS IMPLANTED TO EMBED THE SEPARATED PIECE OF BALLOON. THE STENT WAS POST DILATED WITH A NC TREK NEO BALLOON TO COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT SEQUELA AND NO CLINICALLY SIGNIFICANT DELAY WAS REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Device Embedded In Tissue or Plaque

    MAUDE report 22809597 ↗
  • InjuryJan 27, 2025Material Separation; Material Separation

    IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE RIGHT CORONARY ARTERY. AFTER A STENT WAS DEPLOYED AT THE TARGET LESION, A 4.5X12MM NC TREK BALLOON DILATATION CATHETER WAS USED FOR POST DILATATION AND INFLATED TWICE TO 9ATM AND 12ATM; HOWEVER, AFTER THE BALLOON WAS FULLY DEFLATED, THE BALLOON WAS NOTED TO SEPARATE IN THE VESSEL DURING REMOVAL. THE SEPARATED BALLOON WAS REMOVED BY UTILIZING A GUIDELINER AND ANOTHER TREK BALLOON TO TRAP THE DISLODGED BALLOON INTO THE GUIDELINER WHERE IT WAS REMOVED FROM THE PATIENT. THERE WAS NO ADVERSE PATIENT SEQUELA NOR CLINICAL DELAY REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21248497 ↗
  • MalfunctionJun 13, 2024Material Split, Cut or Torn; Material Split, Cut or Torn

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE BIFURCATION OF THE LEFT ANTERIOR DESCENDING (LAD) ARTERY AND DIAGONAL ARTERY. THE 4.5X12MM TREK RX BALLOON DILATATION CATHETER (BDC) WAS BEING PREPARED WHEN THE INDEFLATOR WAS PUT ON NEGATIVE PRESSURE, THE INDEFLATOR JUST FILLED WITH AIR SUGGESTING A HOLE IN THE BALLOON. ANOTHER 4.5X15MM TREK RX BALLOON WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECT AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19533954 ↗
  • MalfunctionNov 16, 2017Material Rupture

    IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY. REPORTEDLY, TWO 4.5 X 12 MM TREK BALLOONS RUPTURED AT 8 ATMOSPHERES (ATMS) DURING THE 1ST INFLATION. THERE HAD BEEN NO RESISTANCE NOTED DURING ADVANCEMENT OF THE TREK BALLOON CATHETERS. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7037649 ↗
  • MalfunctionNov 16, 2017Material Rupture

    IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY. REPORTEDLY, TWO 4.5 X 12 MM TREK BALLOONS RUPTURED AT 8 ATMOSPHERES (ATMS) DURING THE 1ST INFLATION. THERE HAD BEEN NO RESISTANCE NOTED DURING ADVANCEMENT OF THE TREK BALLOON CATHETERS. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7037643 ↗

Other Catheters, transluminal coronary angioplasty, percutaneous devices

All Catheters, transluminal coronary angioplasty, percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page